Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $1.7B |
| Sales growthchange from the year before | +6.4% |
| Gross marginshare of sales left after the direct cost of what it sells | 88.2% |
| Operating marginshare of sales left after running the business | 67.7% |
| Net marginshare of sales kept as profit | 49.8% |
| Free-cash-flow marginspare cash generated per $100 of sales | 64.5% |
| Return on equityprofit vs. shareholders' accounting value | n/m |
| Debt / equitydebt vs. shareholders' accounting value | n/m |
| Interest coverhow many times profit covers interest payments | 14.6x |
| Change in share countnegative = the company is buying back its shares | -4.5% |
3 insiders sold $3.2M (96% under pre-arranged plans) on the open market.
| Bidzos D JamesExec. Chairman, Pres, & CEO · Director | Sold (plan)Aug 4 | 3,300 shat $296.54 · $979K |
| Indelicarto Thomas CEVP, Gen Counsel & Secretary | Sold (plan)Aug 3 | 500 shat $292.20 · $146K |
| Bidzos D JamesExec. Chairman, Pres, & CEO · Director | Sold (plan)Jul 28 | 3,300 shat $281.20 · $928K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy